During the past decade, Akademiska Sjukhuset; Lungmedicinska Kliniken conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Akademiska Sjukhuset; Lungmedicinska Kliniken" are "Giant Cell Arteritis" (1 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Akademiska Sjukhuset; Lungmedicinska Kliniken" in a lesser frequency.

Most popular intervention types in "Akademiska Sjukhuset; Lungmedicinska Kliniken" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Corticosteroids" (1 trials), "Methotrexate" (1 trials), "Pirfenidone" (1 trials), "Prednisone" (1 trials) and "Prednisone Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Akademiska Sjukhuset; Lungmedicinska Kliniken" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Akademiska Sjukhuset; Lungmedicinska Kliniken". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Akademiska Sjukhuset; Lungmedicinska Kliniken, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Akademiska Sjukhuset; Lungmedicinska Kliniken, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".